Litcius/Paper detail

Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient

Xiaohong Yao, Zhi-Cheng He, Tingyuan Li, Huarong Zhang, Yan Wang, Huaming Mou, Qiao‐Nan Guo, Shi‐Cang Yu, Yanqing Ding, Xindong Liu, Yi‐Fang Ping, Xiu‐Wu Bian

2020Cell Research229 citationsDOIOpen Access PDF

Abstract

SARS-CoV-2, a novel coronavirus and causing COVID-19, has given rise to a worldwide pandemic. 1 , 2 So far, tens of thousands of COVID-19 patients have been clinically cured and discharged, but multiple COVID-19 cases showed SARS-CoV-2 positive again in discharged patients, 3 which raises an attention for the discharged patients. Also, there is an urgent need to understand the pathogenesis of SARS-CoV-2 infection. Here, we conducted postmortem pathologic study in a ready-for-discharge COVID-19 patient who succumbed to sudden cardiovascular accident. Pathological examination revealed SARS-CoV-2-viruses remaining in pneumocytes and virus-caused pathological changes in the lungs. Our study provided new insights into SARS-CoV-2 pathogenesis and might facilitate the improvement of clinical guideline for virus containment and disease management.

Topics & Concepts

BiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PathologicalCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakLungIntensive care medicineBioinformaticsVirologyPathologyInternal medicineDiseaseInfectious disease (medical specialty)MedicineOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 diagnosis using AI